Shaperon is a clinical stage biotech company developing Novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and Nanobody therapeutics
NuGel®
NuSepin®
Oral HY209
Saviximab®
Papiliximab®
Inflammasomes are intracellular multiprotein complex in the innate immune system, the body’s first line of defense against PAMPs or host-derived cellular stress known as DAMPs. Once activated, inflammasomes produce highly proinflammatory cytokines and induce programmed cell death called pyroptosis. Dysregulation of inflammasomes is associated with a vast number of autoimmune and inflammatory disorders.
Nanobody is a single domain antibody that is the variable domain of heavy chain only antibody. It is naturally in the serum of camelidae (Camelid, Lama, Alpaca etc)
To learn more, or schedule a ZOOM meeting, please fill out the form and one of our team members will respond shortly. Thank you!